Decaux G, Mols P, Cauchie P, Flamion B, Delwiche F
Nephron. 1986;44(4):337-43. doi: 10.1159/000184016.
We have studied the efficacy of urea in the treatment of hyponatremia and hydrosaline retention in cirrhotic patients with ascites resistant to diuretics. In 5 patients with hyponatremia and ascites resistant to a major diuretic treatment (200-400 mg spironolactone combined with 40-160 mg furosemide/day for 4 of them), urea intake (30-90 g/day) induced the following changes: the daily weight changed from a gain of 0.01 +/- 0.06 kg/day to a loss of 1.03 +/- 0.12 kg/day (p less than 0.001) (mean +/- SEM), serum sodium concentration rose from 128 +/- 1.3 to 133 +/- 1.4 mmol/l (p less than 0.01), sodium output increased from 24 +/- 4 to 82.5 +/- 11 mmol/day, diuresis increased from 1.05 +/- 0.10 to 2.24 +/- 0.24 liters/day (p less than 0.01). Despite an important weight loss, the creatinine clearance did not change significantly (53.6 +/- 4.5 ml/min before and 70.0 +/- 8.2 ml/min during urea). In patients responding to classical diuretics, urea as a monotherapy was less effective. From the 6 patients with resistant ascites, only 1 developed prerenal uremia after urea treatment. In order to enhance urea efficacy, it is important to take it together with a long-loop diuretic. Intermittent urea intake seemed to be useful in cirrhotic patients with hyponatremia associated with ascites resistant to diuretics and with low or normal blood urea concentrations.
我们研究了尿素对肝硬化腹水患者利尿剂抵抗性低钠血症和水盐潴留的治疗效果。5例低钠血症且对主要利尿剂治疗(其中4例为200 - 400mg螺内酯联合40 - 160mg呋塞米/天)抵抗的腹水患者,摄入尿素(30 - 90g/天)后出现以下变化:每日体重从增加0.01±0.06kg/天变为减轻1.03±0.12kg/天(p<0.001)(均值±标准误),血清钠浓度从128±1.3升至133±1.4mmol/L(p<0.01),钠排出量从24±4增加至82.5±11mmol/天,尿量从1.